The certification will open new avenues for our flagship brand “Dr Trust”, enabling them to export these devices to many more countries
Acquisition brings leading sickle cell disease portfolio and pipeline to Pfizer with potential to address critical needs in an underserved patient community
Study achieves primary endpoint of radiographic progression-free survival
This clinical study will inform operational logistics and use of AV7909 should an anthrax emergency occur.
Dr. Fesharaki most recently served as the Chief Scientific Officer and Global Head of R&D for Hikma Pharmaceuticals.
The proposed acquisition consideration represents an equity value for Myovant of $2.4 billion and an enterprise value of $2.5 billion.
The two-day meeting in the city was organized in collaboration with the University of Birmingham, Christian Medical College Ludhiana, and Birmingham Clinical Trials Unit
Julie Brown is currently Chief Operating and Financial Officer, Burberry Group.
Transformation to pure-play Innovative Medicines company nears completion
Though lungs do not have the celebrity status as the heart, they are one of the most important and delicate organs of the human body
Subscribe To Our Newsletter & Stay Updated
